Otsuka Holdings Co Ltd (4578):企業の財務・戦略的SWOT分析

◆英語タイトル:Otsuka Holdings Co Ltd (4578) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15644
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Otsuka Holdings Co Ltd (4578) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Otsuka Holdings Co Ltd (Otsuka) is a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals, consumer products and other businesses through its subsidiaries. It focuses on the research and development, manufacture, and sale of medicines for the treatment of cancer, cardiovascular diseases, central nervous system disorders, ophthalmic diseases, gastrointestinal and respiratory diseases, infectious diseases, dermatological conditions and allergies. The company’s product portfolio includes pharmaceutical products, cosmetics, functional foods and beverages, alcoholic beverages, fine chemicals, electronic equipment, functional chemicals, medical devices and OTC products. It markets its products in North America, Europe and Asia. Otsuka is headquartered in Chiyoda-ku, Tokyo, Japan.

Otsuka Holdings Co Ltd Key Recent Developments

Jan 04,2019 Otsuka, Click Therapeutics partner to create therapy for mental illness
Jan 03,2019 Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder
Nov 30,2018 Lundbeck and Otsuka report positive phase II data for the combination treatment of brexpiprazole and sertraline for the treatment of Post-Traumatic Stress Disorder (PTSD)
Oct 15,2018 Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Otsuka Holdings Co Ltd – Key Facts
Otsuka Holdings Co Ltd – Key Employees
Otsuka Holdings Co Ltd – Major Products and Services
Otsuka Holdings Co Ltd – History
Otsuka Holdings Co Ltd – Company Statement
Otsuka Holdings Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Otsuka Holdings Co Ltd – Business Description
Business Segment: Consumer Product Business
Overview
Performance
Business Segment: Nutraceutical Business
Overview
Performance
Business Segment: Other Businesses
Overview
Performance
Business Segment: Pharmaceutical Business
Overview
Performance
R&D Overview
Otsuka Holdings Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Otsuka Holdings Co Ltd – Strengths
Otsuka Holdings Co Ltd – Weaknesses
Otsuka Holdings Co Ltd – Opportunities
Otsuka Holdings Co Ltd – Threats
Otsuka Holdings Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Otsuka Holdings Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 04, 2019: Otsuka, Click Therapeutics partner to create therapy for mental illness
Jan 03, 2019: Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder
Nov 30, 2018: Lundbeck and Otsuka report positive phase II data for the combination treatment of brexpiprazole and sertraline for the treatment of Post-Traumatic Stress Disorder (PTSD)
Oct 15, 2018: Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advanced Digital Medicines for Mental Health
Oct 15, 2018: Otsuka expands digital medicines alliance with Proteus Digital
Aug 08, 2018: Otsuka Holdings reports consolidated financial results for the second quarter of the fiscal year ending December 31, 2018
Jul 11, 2018: Otsuka Medical Devices to merge with ReCor Medical
Mar 29, 2018: Otsuka Holdings appoints board members and audit & supervisory board members
Feb 28, 2018: CEOs Leading Scientific Breakthroughs at Otsuka and Spark Therapeutics to Keynote Veeva Commercial & Medical Summit
Feb 14, 2018: Otsuka Holdings announces Consolidated Financial Results for the Fiscal Year Ended December 31, 2017
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Otsuka Holdings Co Ltd, Key Facts
Otsuka Holdings Co Ltd, Key Employees
Otsuka Holdings Co Ltd, Major Products and Services
Otsuka Holdings Co Ltd, History
Otsuka Holdings Co Ltd, Subsidiaries
Otsuka Holdings Co Ltd, Key Competitors
Otsuka Holdings Co Ltd, Ratios based on current share price
Otsuka Holdings Co Ltd, Annual Ratios
Otsuka Holdings Co Ltd, Annual Ratios (Cont...1)
Otsuka Holdings Co Ltd, Annual Ratios (Cont...2)
Otsuka Holdings Co Ltd, Interim Ratios
Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Otsuka Holdings Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Otsuka Holdings Co Ltd, Performance Chart (2014 - 2018)
Otsuka Holdings Co Ltd, Ratio Charts
Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Otsuka Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Otsuka Holdings Co Ltd (4578):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CTI BioPharma Corp (CTIC)-製薬・医療分野:企業M&A・提携分析
    Summary CTI BioPharma Corp (CTI BioPharma) is a biopharmaceutical company, which acquires, develops, and commercializes targeted therapies for a range of blood-related cancers. The company’s lead product, Pixuvri (pixantrone) is an aza-anthracenedione used for the treatment of multiply relapsed or r …
  • Adamis Pharmaceuticals Corp (ADMP):医療機器:M&Aディール及び事業提携情報
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • HESTA Super Fund:企業の戦略的SWOT分析
    HESTA Super Fund - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Eisai Inc-製薬・医療分野:企業M&A・提携分析
    Summary Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemoth …
  • Valneva SE:企業のM&A・事業提携・投資動向
    Valneva SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Valneva SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • BPCE SA:企業のM&A・事業提携・投資動向
    BPCE SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BPCE SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Esterline Technologies Corporation:企業の戦略・SWOT・財務情報
    Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Esterline Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • FUJIFILM Medical Systems USA Inc:企業の戦略的SWOT分析
    FUJIFILM Medical Systems USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Cell Medica Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cell Medica Ltd (Cell Medica), formerly Immunocode Ltd manufactures and commercializes cellular products. The company uses various technology platforms such as chimeric antigen receptor (CAR), Dominant T cell receptor (TCR), PENTRA Antibody technology and NKT cell platform for manufacturing …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pilot Energy Ltd (PGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Pilot Energy Ltd (Pilot), formerly Rampart Energy Ltd is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in Australia. Its projects include Australia EP416 and EP480, Australia WA-507-P, Australia WA-503-P and Aus …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) operates as a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testoster …
  • Electronic Control Security Inc.:企業の戦略・SWOT・財務情報
    Electronic Control Security Inc. - Strategy, SWOT and Corporate Finance Report Summary Electronic Control Security Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • QIMR Berghofer Medical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary QIMR Berghofer Medical Research Institute (QIMR), formerly Queensland Institute of Medical Research is a medical research institute that offers education and research programs. The institute offers its research programs in the areas of mental health, cancer, infectious disease, and complex d …
  • University of Helsinki:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Helsinki (UOH) is an educational service provider that offers research and graduate programs. The university operates through independent institutes and faculties for theology, law, medicine, arts, science, pharmacy, biological and environmental sciences, behavioral sciences, s …
  • VolitionRX Ltd (VNRX):企業の製品パイプライン分析2018
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • Capsugel Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the b …
  • Jouve SA:企業の戦略的SWOT分析
    Jouve SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Dongwon F&B Co., Ltd.:企業の戦略・SWOT・財務情報
    Dongwon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dongwon F&B Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆